Kidney disease is fast emerging as a global concern with the potential to devastate millions of lives. Recent advances in early detection of Chronic Kidney Disease (CKD) for people most at risk are making prevention and early treatment a reality. For example, during the past decade, studies from around the world have established microalbuminuria as the critical indicator for early stage kidney disease, as well as a significant risk factor for cardiovascular disease.
Siemens Healthcare Diagnostics’ comprehensive suite of products for near patient and point-of-care urinalysis testing help physicians identify those patients most at risk of developing kidney disease. For example: